Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
出版年份 2020 全文链接
标题
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-23
DOI
10.1186/s12967-020-02522-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification and validation of immune-related lncRNA prognostic signature for breast cancer
- (2020) Yong Shen et al. GENOMICS
- Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer
- (2020) Muhammad Tarek Abdel Ghafar et al. MOLECULAR BIOLOGY REPORTS
- Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
- (2020) Le Zhang et al. Molecular Cancer
- Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study
- (2020) Muhammad Tarek Abdel Ghafar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21
- (2020) Zhuolu Wang et al. Frontiers in Endocrinology
- Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
- (2020) Bei Li et al. Frontiers in Oncology
- Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis
- (2020) Zhigang Yuan et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Immunotherapy in Anal Cancer
- (2020) Lisa Phuong et al. Current Oncology Reports
- Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway
- (2019) Gang Wang et al. Molecular Cancer
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma
- (2019) Yuting He et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
- (2019) Miki Takata et al. Frontiers in Immunology
- Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
- (2019) Na Li et al. EPMA Journal
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
- (2019) Mahnaz Sahraei et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer
- (2019) Kehao Le et al. Scientific Reports
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- The regulation of lymphocyte activation and proliferation
- (2018) Susanne Heinzel et al. CURRENT OPINION IN IMMUNOLOGY
- Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study
- (2018) Abbas Shafiee et al. INTERNATIONAL JOURNAL OF CANCER
- ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
- (2018) Sanchita Bhattacharya et al. Scientific Data
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma
- (2018) Li Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiles of long noncoding RNAs in lung adenocarcinoma
- (2018) Bing Zhao et al. OncoTargets and Therapy
- Research progresses in roles of LncRNA and its relationships with breast cancer
- (2018) Xu Bin et al. Cancer Cell International
- Long noncoding RNA s as regulators of cancer immunity
- (2018) Nerina Denaro et al. Molecular Oncology
- Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells
- (2018) Chulwoo Kim et al. Cell Reports
- Intergenic variants may predispose to major depression disorder through regulation of long non-coding RNA expression
- (2017) Ning Ye et al. GENE
- Cytokine-Mediated Regulation of Human Lymphocyte Development and Function: Insights from Primary Immunodeficiencies
- (2017) Stuart G. Tangye et al. JOURNAL OF IMMUNOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System
- (2017) Mariana Chavez‐MacGregor et al. ONCOLOGIST
- The functions of long noncoding RNAs in development and stem cells
- (2016) Rotem Ben-Tov Perry et al. DEVELOPMENT
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- From Discovery to Function: The Expanding Roles of Long NonCoding RNAs in Physiology and Disease
- (2015) Miao Sun et al. ENDOCRINE REVIEWS
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
- (2015) Wen Cheng et al. Oncotarget
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
- (2008) Wen-Jin Yin et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started